Sector pending / Drugs, Drug Proprietaries, and Druggists' SundriesUpdated 2026-05-10 22:07 UTC

BOM/542934 stock hub

BOM/542934 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/542934is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

238.4M

Bombay Stock Exchange

Market data

Price

Recent price action with selectable time range.

BOM/542934BOM/542934

—

Loading chart…

In the news

Latest news · BOM/542934

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E38.2

P25 n/aP50 n/aP75 n/a

ROE2.1

P25 n/aP50 n/aP75 n/a

ROIC2.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/542934 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

INR

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	40
Employees Change	3%
Employees Change Percent	8.11
Enterprise value	INR 423.8M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Last refreshed	2026-05-10
Market cap	INR 238.4M
Price	INR 31.6
Price currency	INR
Rev Per Employee	12,348,650x
Sic	5122
Symbol	bom/542934
Website	https://www.cbcpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.61%
EV Earnings	68.14x
EV/EBIT	19.63x
EV/EBITDA	13.08x
EV/FCF	29.54x
EV/Sales	0.86x
FCF yield	6.02%
P/B ratio	0.78x
P/E ratio	38.23x
P/S ratio	0.48x
PE Ratio10 Y	86.85x
PE Ratio3 Y	45.13x
PE Ratio5 Y	54.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.37%
EBITDA Margin	6.56%
FCF margin	2.91%
Gross margin	27.65%
Gross Profit	INR 136.6M
Gross Profit Growth	-10.64%
Gross Profit Growth Q	-17.61%
Gross Profit Growth3 Y	-1.36%
Gross Profit Growth5 Y	1.14%
Net Income	INR 6.2M
Net Income Growth	-60.64%
Net Income Growth Q	-34.43%
Net Income Growth3 Y	-25.93%
Net Income Growth5 Y	-7.23%
Pretax Margin	2.37%
Profit Margin	1.26%
Profit Per Employee	INR 155,500
ROA	1.48
Roa5y	3.09
ROCE	6.92
ROE	2.07
Roe5y	3.09
ROIC	2.34
Roic5y	5.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-47.36%
Cagr3y	-33.99%
Cagr5y	-8.59%
EPS Growth	-60.62
EPS Growth Q	-34.07
EPS Growth3 Y	-25.86
EPS Growth5 Y	-7.18
FCF Growth3 Y	-28.3%
FCF Growth5 Y	-21.76%
OCF Growth	774.24%
OCF Growth3 Y	-24.41%
OCF Growth5 Y	-12.71%
Revenue Growth	-70.63x
Revenue Growth Q	-60.65x
Revenue Growth3 Y	-39.45x
Revenue Growth5 Y	-16.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.54
Assets	INR 882M
Cash	INR 25.7M
Current Assets	INR 849.3M
Current Liabilities	INR 569.8M
Debt	INR 211.1M
Debt EBITDA	INR 6.52
Debt Equity	INR 0.69
Debt FCF	INR 14.71
Equity	INR 304.2M
Interest Coverage	1.23
Liabilities	INR 577.8M
Long Term Assets	INR 32.7M
Long Term Liabilities	INR 8M
Net Cash	INR -185.4M
Net Cash By Market Cap	INR -77.77
Net Debt EBITDA	INR 5.72
Net Debt Equity	INR 0.61
Net Debt FCF	INR 12.92
Tangible Book Value	INR 304.2M
Tangible Book Value Per Share	INR 40.64
WACC	3.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.49
Inventory Turnover	19.27
Net Working Capital	INR 457.1M
Quick ratio	0.57
Working Capital	INR 279.4M
Working Capital Turnover	INR 1.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-47.33%
200-day SMA	58.65
3Y total return	-71.25%
50-day SMA	38.25
50-day SMA vs 200-day SMA	50under200
5Y total return	-36.16%
All Time High	160
All Time High Change	-80.25%
All Time High Date	2023-12-20
All Time Low	29.7
All Time Low Change	6.4%
All Time Low Date	2026-05-06
ATR	2.21
Beta	-0.35
Beta1y	0.14
Beta2y	0.04
Ch YTD	-23.39
High	31.6
High52	61.5
High52 Date	2025-06-04
High52ch	-48.62%
Low	29.7
Low52	29.7
Low52 Date	2026-05-06
Low52ch	6.4%
Ma50ch	-17.38%
Price vs 200-day SMA	-46.12%
RSI	37.92
RSI Monthly	30.95
RSI Weekly	31.06
Sharpe ratio	-1.09x
Sortino ratio	-1.46
Total Return	0.06%
Tr YTD	-23.39
Tr1m	-1.25%
Tr3m	-25.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 21.6M
Operating Income Growth	-2.91
Operating Income Growth Q	-4.44
Operating Income Growth3 Y	-12.01
Operating Income Growth5 Y	-10.05
Operating margin	4.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,295,000%
Net Borrowing	-18,153,000
Shares Insiders	73.76%
Shares Institutions	7.3%
Shares Out	7,545,056
Shares Qo Q	-1.04%
Shares Yo Y	-0.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 14.4M
Average Volume	7,050x
Bv Per Share	40.64
CAPEX	INR -12.3M
Ch1m	-1.25
Ch1y	-47.33
Ch3m	-25.12
Ch3y	-71.25
Ch5y	-36.16
Ch6m	-21.02
Change	0%
Change From Open	1.64
Depreciation Amortization	10,806,000
Dollar Volume	379,200
Earnings Date	2026-05-22
EBIT	INR 21.6M
EBITDA	INR 32.4M
EPS	INR 0.83
F Score	7
FCF	INR 14.4M
FCF EV Yield	3.39x
FCF Per Share	INR 1.9
Financing CF	-37,249,000
Fiscal Year End	March
Founded	1,944
Graham Number	27.4931
Graham Upside	-13
Income Tax	INR 5.5M
Investing CF	-2,594,000
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-09-30
Lynch Fair Value	INR 4.13
Lynch Upside	-86.92
Ma150	53.59
Ma150ch	-41.04%
Ma20	33.91
Ma20ch	-6.82%
Net CF	-13,169,000
Next Earnings Date	2026-05-22
Open	31.09
P FCF Ratio	16.61
P OCF Ratio	8.94
Position In Range	100
Ppne	20,425,000
Price Date	2026-05-06
Price EBITDA	INR 7.36
Ptbv Ratio	0.78
Relative Volume	1.7x
Revenue	493,946,000x
Tax By Revenue	1.11x
Tax Rate	46.95%
Tr6m	-21.02%
Volume	12,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/542934 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/542934 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/542934?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.3%

Share of float held by funds and institutions

Insider ownership

+73.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

BOM/542934 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.9

Neutral momentum band

Price vs 200-day MA

-46.1%

50/200-day relationship not available

Beta (5Y)

-0.35

Less volatile than the market

Sharpe ratio

-1.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/542934

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/542934 stock rating?

bom/542934 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/542934 analysis?

The full report lives at /stocks/bom/542934/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/542934?

The latest report frames bom/542934 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/542934 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.